BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18758376)

  • 21. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes.
    Fang FM; Li CF; Chien CY; Rau KM; Huang HY
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
    Miao R; Liu N; Wang Y; Li L; Yu X; Jiang Y; Li J
    Hepatogastroenterology; 2008; 55(88):2012-5. PubMed ID: 19260469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular determinants in targeted therapy for esophageal adenocarcinoma.
    Vallböhmer D; Peters JH; Kuramochi H; Oh D; Yang D; Shimizu D; DeMeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; Danenberg PV; DeMeester TR
    Arch Surg; 2006 May; 141(5):476-81; discussion 481-2. PubMed ID: 16702519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of vascular endothelial growth factor and nm23 as prognostic factors in nasopharyngeal carcinoma].
    Zhang G; Zeng J; Gong L; Wu G; Zhou Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):372-5. PubMed ID: 12761948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
    Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
    Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
    Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis].
    Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
    Nasr HB; Chahed K; Bouaouina N; Chouchane L
    Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of vascular endothelial growth factor in Indonesian advanced stage nasopharyngeal carcinoma.
    Kurnianda J; Hardianti MS; Harijadi ; Taroeno-Hariadi KW; Purwanto I; Haryana SM; Tjokronagoro MS
    Kobe J Med Sci; 2009 Jun; 55(2):E36-44. PubMed ID: 20847590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma.
    Taheri-Kadkhoda Z; Magnusson B; Svensson M; Mercke C; Björk-Eriksson T
    Head Neck; 2009 Apr; 31(4):482-92. PubMed ID: 19132724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
    von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M
    Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors.
    Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R
    Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.